Navigation Links
Glucose challenge test is accurate and economical for diabetes and prediabetes screening
Date:6/25/2009

A test commonly used to help identify women with diabetes during pregnancy may be an accurate, convenient and inexpensive way to screen the general population for unrecognized diabetes and prediabetes, according to Emory University researchers.

A test commonly used to help identify women with diabetes during pregnancy may be an accurate, convenient and inexpensive way to screen the general population for unrecognized diabetes and prediabetes, according to Emory University researchers.

The results of the study, "Glucose challenge test screening for prediabetes and undiagnosed diabetes" will be published online and in print in the journal Diabetologia.

"Widespread use of the glucose challenge test (GCT) to screen Americans for prediabetes and diabetes could provide a major opportunity to improve the health of more than 40 million people," said lead study author Lawrence S. Phillips, MD, Emory University School of Medicine Professor of Medicine, Division of Endocrinology.

The study screened 1,573 volunteer participants who had never been diagnosed with diabetes. At a first visit, at different times of the day and without restriction of meals, participants were given a 50-gram glucose drink. Glucose was measured both before the drink (random glucose) and an hour after the drink (GCT glucose).

At a follow-up visit held in the morning after an overnight fast, participants had measurement of hemoglobin A1c (a standard test used to monitor diabetes), and a 75-gram oral glucose tolerance test (OGTT). The OGTT is the "gold standard" for diagnosing diabetes and prediabetes.

After screening, researchers found that 4.6 percent of the participants had previously unrecognized diabetes, and 18.7 percent had prediabetes.

The GCT was the most accurate screening test for these problems, significantly better than the random glucose or A1c tests. Since the good performance of the GCT was unaffected by the tim
'/>"/>

Contact: Jennifer Johnson
jrjohn9@emory.edu
404-727-5696
Emory University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Scientists explain how insulin secreting cells maintain their glucose sensitivity
2. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
3. Increased glucose level is a strong risk factor for colorectal cancer
4. Got sugar? Glucose affects our ability to resist temptation
5. Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
6. MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
7. Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
8. Notch-ing glucose into place
9. Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
10. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
11. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... No more letters from the North Pole, Textsanta....sages from Santa , North ...tional efficiencies at the North Pole Santa Claus ... all over the globe informed of his Christmas prog... research department have identified a large and g...
(Date:11/26/2009)... Benton Communications announces a highly effect...retailers struggling to make an economic recovery....009 -- Flu fears is the type of challenge that cou..., according to Dr. David Benton, business growth e...owth system – The Rfactor Intensive . &ld...
(Date:11/25/2009)...Nov.25/PRNewswire/--TheBartleHallConventionCenterw...conDec.9-10,whenKansasCityhoststhelatestinaserieso...freecliniceventhasthepotentialtobethebiggestoneyet...beheldonweekdaysinsteadofoveraweekend,"SheriWood,e...presidentoftheNationalAssociationofFreeClinics(NAF...
(Date:11/25/2009)...PRNewswire/-SentinelleMedicalInc.,aleadingmanufact...relaunchesasuiteofnewleadingedgeclinicalapplicatio...isyear,sRadiologicalSocietyofNorthAmerica(RSNA)ann...llA).Theapplicationsleveragetheuniquehighqualityim...ilsandsupportmultipleimagingmodalitiesformulti-par...
(Date:11/25/2009)...25/PRNewswire-USNewswire/--TheBlackAIDSInstitutere...tiveleadershipfor2010. ,, ThenewBoardMembersare...cpolicy,law,finance,governmenthealthprograms,edito...fromawiderangeofpersonalbackgroundsincludingbothhe...themselves,andrepresentingmultipleagegroups. ,,...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...oday revealed that there is a “crisis” over lack o...BC, with some of the clinics being totally out of ...n were facing a major problem. In 1990s, the h... to know the identity of their donor father at the...
...g developed that would reduce the bio-terrorism th...// Biomedical researchers at the University ...nnounced to start the initial step in the developm...rmined the specific structure of a protein that th...
...merican firms have jointly developed a new lifelon...eishmaniasis (VL), the second most deadly// parasi...wn in India. The drug was prepared by OneWorl...rma Limited, the American company announced. ...
...sioned by the World Health Organization has sugges... any, treatments may work against SARS// in the ev...me 70 studies that was conducted during and after ...t some could have caused more harm than good, says...
...e, effective cancer therapies has led numerous aca...e oncolytic, or cancer-killing viruses//. Oncolyti...ovirus, infect cancer cells while sparing healthy ...es clear rapidly from the body without harming the...
... have announced a hike of 5.6 percent for basic Me... premiums for the wealthier// beneficiaries will i...the federal government has required the affluent t...ctor visits and outpatient hospital care, will ris...
Other Medicine News:Health News:Shortage of donors at sperm bank clinics 2Health News:A New drug Developed To Fight The Bio-Terrorism Threat Of VEE Virus 2Health News:US, India Firms Develop New Cure for Black Fever 2Health News:US, India Firms Develop New Cure for Black Fever 3Health News:Treatment of SARS Still a Mystery 2Health News:Cancer-Killing Viruses Employ Multiple Mechanisms 2Health News:Cancer-Killing Viruses Employ Multiple Mechanisms 3Health News:Medicare Premiums to be Higher Next Year 2
(Date:11/25/2009)...irstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicalde...disruptivesurgicaltreatmentsforthespine,announcedt...30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecallw...heCompany,sproductsandwillincludecommentsfrommanag...ial-innumbersare1-877-407-4018fordomesticcallersan...
(Date:11/25/2009)...Reportlinker.comannouncesthatanewmarketresearchrep...gDelivery-USMarketTrends&Analysis http://www....---US-Market-Trends--Analysis.html ,, TheUSint...therapeuticapplicationsfromthedeliveryofconvention...apeuticdrugs.Thefutureofthetechnologyhingesontothe...
(Date:11/25/2009)...RNewswire/-- ChemoCentryx,Inc.,announcedtodaythat...heProspectiveRandomizedOralTherapyEvaluationinCroh...ntswithmoderate-to-severeCrohn,sdiseasedemonstrate...typrofile.Thestudydemonstratedevidenceofclinicalef...0-pointdecreaseintheCrohn,sDiseaseActivityIndex(CD...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 1Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 2Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 3SRA International Wins 2416 Million Contract from Cancer Prevention and Research Institute of Texas 13952 1SRA International Wins 2416 Million Contract from Cancer Prevention and Research Institute of Texas 13952 2SRA International Wins 2416 Million Contract from Cancer Prevention and Research Institute of Texas 13952 3FDA Advisory Committee Makes Favorable Recommendation for Cervarix GlaxoSmithKlines Candidate Cervical Cancer Vaccine 13951 1FDA Advisory Committee Makes Favorable Recommendation for Cervarix GlaxoSmithKlines Candidate Cervical Cancer Vaccine 13951 2FDA Advisory Committee Makes Favorable Recommendation for Cervarix GlaxoSmithKlines Candidate Cervical Cancer Vaccine 13951 3FDA Advisory Committee Makes Favorable Recommendation for Cervarix GlaxoSmithKlines Candidate Cervical Cancer Vaccine 13951 4
...USALEM, July 31 Oramed Pharmaceuticals,Inc. (OTCB... oral delivery,systems, announced today that it wi...0 AM EDT to present the results of its Phase 2A cl...an oral insulin capsule., Oramed,s Phase 2A trial...f ORMD 0801. This study is a continuation of the s...
...lus, Taking Antidementia Drugs Extends Lifespan Th...ults from clinical,trials of three potential Alzhe...atments of the disease, according to data reported...tional Conference on Alzheimer,s,Disease (ICAD 200...g antidementia drugs appears to have a,positive im...
Other Medicine Technology:Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials 2Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 2Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 3Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 4Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 5Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 6Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 7Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 8Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD 9
Spyglass
8F Standard
5F Infiniti
Leksell Neuro Generator
Medicine Products: